148
10
5
20
Cat. No. | Product Name | ||
---|---|---|---|
L1200 | 表观遗传库 | 953 compounds | |
953 种表观遗传学研究相关的生物活性小分子的特有集合,用于表观遗传学研究及其相关的检测和高通量、高内涵筛选; | |||
L3500 | 组蛋白修饰化合物库 | 469 compounds | |
469 个组蛋白修饰相关的小分子化合物的特有集合,用于高通量、高内涵筛选; | |||
L8200 | 抗衰老化合物库 | 3279 compounds | |
3279 个抗衰老化合物的独特集合,可用于高通量筛选和高内涵筛选; | |||
L8300 | 染色质修饰分子库 | 250 compounds | |
250 种染色质化学修饰相关的生物活性小分子化合物的特有集合,用于高通量、高内涵筛选; | |||
L2140 | 癌细胞分化化合物库 | 406 compounds | |
406 个诱导肿瘤细胞分化化合物的独特集合,可用于高通量筛选和高内涵筛选; |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T72013 |
Epigenetic Multiple Ligand
|
Others | Others |
Epigenetic Multiple Ligand is a cell-permeable inhibitor of substrate processing by several chromatin-associated enzymes, including SIRT1/2, H3/SET7, H3/p300/CBP, H4/RmtA, PABP1/CARM1, and H4/PRMT1. It acts by inducing either apoptosis or granulocytic differentiation. | |||
T82458 |
Epigenetic factor-IN-1
|
Sirtuin | Chromatin/Epigenetic; DNA Damage/DNA Repair |
Epigenetic factor-IN-1(40569Z)是一种针对SIRT7显示出强效结合能力的表观遗传因子抑制剂,常用于肝癌的研究领域。 | |||
T15424 |
GSK1379725A
|
Epigenetic Reader Domain | Chromatin/Epigenetic |
GSK1379725A 是一种选择性 BPTF 配体,Kd 为 2.8 μM。 | |||
T11925 |
M‑89
|
Epigenetic Reader Domain; Histone Methyltransferase | Chromatin/Epigenetic |
M-89 可抑制 Menin-MLL 蛋白之间的相互作用,有研究混合谱系白血病的潜力。它是一种强特异性 menin 抑制剂,结合到 menin 的Kd 值为 1.4 nM。 | |||
T2072 |
BET bromodomain inhibitor
|
Epigenetic Reader Domain | Chromatin/Epigenetic |
BET bromodomain inhibitor 是 BET 的一种有效抑制剂。 | |||
T16072 |
MI-538
|
Epigenetic Reader Domain; Histone Methyltransferase | Chromatin/Epigenetic |
MI-538是一种menin 和MLL 融合蛋白相互作用的抑制剂,IC50值为 21 nM。 | |||
T16321 |
NI-42
|
Epigenetic Reader Domain | Chromatin/Epigenetic |
NI-42 是一种用于 BRPF 的结构正交化学探针,是有偏向性的BRPFs 溴结构域 (BRD)抑制剂,BRPF1、2和3的IC50为7.9、48和260 nM; BRPF1、2和3的Kd 值为40、210和940 nM,与非分类 IV BRD 蛋白相比具有很好的选择性。 | |||
T3311 |
GSK6853
|
Epigenetic Reader Domain | Chromatin/Epigenetic |
GSK6853 是一种强选择性RPF1乙酰赖氨酸抑制剂,pKd 为9.5,其选择性是其它的乙酰赖氨酸的 1600 倍。 | |||
T5362 |
Y06036
|
Epigenetic Reader Domain | Chromatin/Epigenetic |
Y06036 是一种选择性 BET 抑制剂,具有抗肿瘤活性,可与 BRD4(1)溴结构域结合,Kd 值为 82 nM。 | |||
T13363 |
Y06137
|
Epigenetic Reader Domain; PKC | Chromatin/Epigenetic; Cytoskeletal Signaling |
Y06137 是一种有效的特异性 BET 抑制剂,对 BRD4(1) 溴结构域的 Kd 为 81 nM。 Y06137可用于去势抵抗性前列腺癌治疗的研究。 | |||
T3973 |
PF-CBP1
|
Epigenetic Reader Domain | Chromatin/Epigenetic |
PF-CBP1 是一种高选择性的 CREB 结合蛋白 (CREBBP) 溴结构域抑制剂。它抑制 CREBBP (IC50: 125 nM) 和 p300 溴结构域 (IC50: 363 nM)。 | |||
T5442 |
A1874
|
Epigenetic Reader Domain; PROTACs | Chromatin/Epigenetic; PROTAC |
A1874 是一种基于 nutlin 的 BRD4 降解 PROTAC,可诱导细胞中的 BRD4 降解,DC50值为 32 nM。它有效抑制许多癌细胞系的增殖。 | |||
T17311 |
(+)-JQ1 PA
|
Epigenetic Reader Domain | Chromatin/Epigenetic |
(+)-JQ1 PA 是一种溴结构域和末端外 (BET) 抑制剂 JQ1 的衍生物,IC50 为 10.4 nM。 | |||
T9568 |
SGC-SMARCA-BRDVIII
|
Epigenetic Reader Domain | Chromatin/Epigenetic |
SGC-SMARCA-BRDVIII 是SMARCA2/4和PB1(5)选择性抑制剂,其Kd 值分别为 35 nM,36 nM 和 13 nM。它还抑制PB1(2)和PB1(3),Kd 值分别为 3.7 和 2.0 μM。它可阻断 3T3-L1 鼠成纤维细胞的脂肪生成。 | |||
T4495 |
dBET1
|
Epigenetic Reader Domain; PROTACs | Chromatin/Epigenetic; PROTAC |
dBET1 是一种由 BRD4 抑制剂 JQ1 与 NSC 527179 衍生物通过 linker 产生的 PROTAC,可诱导 BRD4 降解。它是由Cereblon 配体和BRD4配体相连的PROTAC,其EC50值为 430 nM。 | |||
T5440 |
Dbet57
|
Epigenetic Reader Domain; PROTACs | Chromatin/Epigenetic; PROTAC |
dBET57 是基于 PROTAC 技术的 BRD4 异双功能降解剂,对 BRD4BD1 有显著降解作用,DC50/5h 为 500 nM。 | |||
T6668 |
SGC-CBP30
|
Epigenetic Reader Domain; Histone Acetyltransferase | Chromatin/Epigenetic |
SGC-CBP30 是高选择性CBP/p300溴结构域的有效抑制剂,对CBP 和p300的Kd 值分别为 21 和 32 nM。它强烈减少 Th17 细胞中 IL-17A 的分泌,具有抗炎作用。 | |||
T5130 |
dBET6
|
Apoptosis; Epigenetic Reader Domain; PROTACs | Apoptosis; Chromatin/Epigenetic; PROTAC |
dBET6 是一种基于 PROTAC 的选择性和细胞渗透性 BET 降解剂,IC50值为 14 nM。 它具有抗肿瘤活性。 | |||
T6786 |
BI-9564
BI 9564,BI9564 |
Epigenetic Reader Domain | Chromatin/Epigenetic |
BI-9564 是一种选择性的且可透过细胞的 BRD9/BRD7溴结构域抑制剂,IC50分别为 75 和 3.4 μM,Kd 为 14 和 239 nM。它对 BET 家族的 IC50值大于 100 μM。 | |||
T17350 |
ACBI1
|
Apoptosis; Epigenetic Reader Domain; PROTACs | Apoptosis; Chromatin/Epigenetic; PROTAC |
ACBI1 是一种基于PROTAC 技术的 BAF ATPase 亚基SMARCA2和SMARCA4降解剂,也是 PBAF 成员PBRM1的降解剂。它由一个 bromodomain 配体、linker 和 E3 泛素连接酶von Hippel-Lindau 构成,能诱导抗增殖作用和凋亡。 | |||
TQ0253 |
PLX51107
|
Epigenetic Reader Domain | Chromatin/Epigenetic |
PLX51107 是一种选择性 BET 抑制剂,与 CBP 和 EP300 的结构域相互作用。它对 BRD2、BRD3、BRD4 和 BRDT 的 BD1 结构域的亲和力Kd 值分别为 1.6、2.1、1.7 和 5 nM,BD2 结构域亲和力Kd 值分别为 5.9、6.2、6.1 和 120 nM。 | |||
TQ0083 |
NI-57
|
Epigenetic Reader Domain | Chromatin/Epigenetic |
NI-57 是溴结构域和植物同源锌指结构域 (BRPF) 蛋白家族的一种抑制剂,对 BRPF1、BRPF2 (BRD1) 和 BRPF3 的 IC50值分别为 3.1、46 和 140 nM。 | |||
TQ0058 |
MI-463
|
Epigenetic Reader Domain; Histone Methyltransferase | Chromatin/Epigenetic |
MI-463 是一种有口服活性的menin-mLL 相互作用的高效小分子抑制剂,IC50为15.3 nM。 | |||
TQ0069 |
MI-503
|
Epigenetic Reader Domain; Histone Methyltransferase | Chromatin/Epigenetic |
MI-503 是一种高效且可口服的 menin-mLL 相互作用抑制剂。 | |||
T14685 |
BMS-986158
|
Epigenetic Reader Domain | Chromatin/Epigenetic |
BMS-986158 是一种BET 抑制剂,在 MDA-MB231 三阴性乳腺癌细胞和 NCI-H211 小细胞肺癌细胞中,对 BET 的IC50分别为 5 和 6.6 nM。 | |||
T9749 |
FHD-286
|
Epigenetic Reader Domain | Chromatin/Epigenetic |
FHD-286 是 BRM/BRG1 ATPase 的抑制剂,可用于治疗 BAF 相关疾病如急性髓性白血病的研究。 | |||
T6783 |
BI-7273
|
Epigenetic Reader Domain | Chromatin/Epigenetic |
BI7273 是一种选择性的可细胞透过BRD9抑制剂,IC50和Kd 分别为 19 和 0.75 nM。它对 BRD7 的作用较强,IC50和Kd 值分别为 117 和 0.3 nM。 | |||
T19935 |
XD14
|
Epigenetic Reader Domain | Chromatin/Epigenetic |
XD14 是BET 抑制剂,其与 BRD2、BRD3 和 BRD4 的结合常数分别为 170 nM、380 nM 和 160 nM。它具有抗肿瘤活性。 | |||
T1854 |
MS436
|
Epigenetic Reader Domain | Chromatin/Epigenetic |
MS436 是溴结构域抑制剂,作用于 BRD4 BrD1的Ki 为 30 到 50 nM 之间,比作用于 BrD2 选择性高 10 倍。 | |||
T2127 |
OF-1
|
Epigenetic Reader Domain | Chromatin/Epigenetic |
OF-1 是溴结构域的一种抑制剂,其对TRIM24 和BRPF1B 的IC50值分别为270 mM 和1.2 μM。 | |||
T12112 |
MS402
|
Epigenetic Reader Domain | Chromatin/Epigenetic |
MS402 是一种新型 BD1 选择性 BET BrD 抑制剂,阻断 Th17 细胞分化并改善小鼠结肠炎,对BRD4(BD1)、BRD4(BD2)、BRD3(BD1)、BRD3(BD2)、BRD2(BD1)和BRD2(BD2)的Ki 分别为 77 、718、110、200、83 和 240 nM。 | |||
T4345 |
CeMMEC1
CeMMEC1 HCl |
Epigenetic Reader Domain; Carboxypeptidase; DNA/RNA Synthesis | Cell Cycle/Checkpoint; Chromatin/Epigenetic; DNA Damage/DNA Repair; Proteases/Proteasome |
CeMMEC1 是一种 BRD4 抑制剂,对 TAF1 有很好的亲和力,IC50为0.9 μM。 | |||
T11136 |
E-7386
E7386 |
Epigenetic Reader Domain | Chromatin/Epigenetic |
E-7386 是是一种有口服活性的 CBP/-catenin 调节剂。 | |||
T17697 |
BRD7-IN-1
|
Epigenetic Reader Domain | Chromatin/Epigenetic |
BRD7-IN-1 是一种修饰的 BI7273 衍生物 (BRD7/9 抑制剂)。BRD7-IN-1 通过与 VHL 配体连接形成 PROTAC VZ185。VZ185 抑制 BRD7/9 的 DC50分别是 4.5 nM 和1.8 nM。 | |||
T5417 |
INCB-057643
|
Apoptosis; Epigenetic Reader Domain | Apoptosis; Chromatin/Epigenetic |
INCB-057643 是一种有效的、选择性的和口服生物可利用的 BET 抑制剂。 | |||
T5434 |
ARV-825
|
Epigenetic Reader Domain; PROTACs | Chromatin/Epigenetic; PROTAC |
ARV-825 是一种双功能 PROTAC,蛋白水解靶向嵌合体,将 BRD4 募集到 E3 泛素连接酶大脑中,导致 BRD4 在所有测试的 BL 细胞系中快速、有效和延长降解。对 BRD4 的 BD1 和 BD2 结构域具有高亲和力,Kd 值分别为 90 和 28 nM。 | |||
T5435 |
ARV-771
|
Epigenetic Reader Domain; PROTACs | Chromatin/Epigenetic; PROTAC |
ARV-771 是基于 PROTAC 技术的有效 BET 降解剂,对 BRD2(1)、BRD2(2)、BRD3(1)、BRD3(2)、BRD4 (1) 和 BRD4(2)的 Kd 分别为 34、4.7、8.3、7.6、9.6 和 7.6 nM。 | |||
T6021 |
GSK1324726A
I-BET726 |
Apoptosis; Epigenetic Reader Domain | Apoptosis; Chromatin/Epigenetic |
GSK1324726A (I-BET726) 是一种选择性有效的BET 蛋白抑制剂,高亲和力结合到BRD2、BRD3和BRD4,IC50值分别为 41 nM、31 nM 和 22 nM。 | |||
T2252 |
UNC 669
UNC669 |
Epigenetic Reader Domain | Chromatin/Epigenetic |
UNC 669是一种有效且特异性的 MBT(恶性脑瘤)抑制剂,是甲基赖氨酸结合结构域的配体,是L3MBTL1和L3MBTL3的抑制剂,IC50分别为 4.2 和 3.1 uM。 | |||
T2436 |
GSK2801
|
Apoptosis; Epigenetic Reader Domain | Apoptosis; Chromatin/Epigenetic |
GSK2801 是一种有口服活性的和细胞活性的乙酰赖氨酸竞争性BAZ2A 和BAZ2B 溴结构域选择性抑制剂,Kd 值分别为 136 nM 和 257 nM。 | |||
T6939 |
PFI-3
PFI 3 |
Epigenetic Reader Domain | Chromatin/Epigenetic |
PFI-3是一种选择性,可渗透细胞的SMARCA2/4溴结构域抑制剂,Kd 值为89 nM,可延迟和预防乳腺癌。 | |||
T13974 |
ZL0580
|
Epigenetic Reader Domain; HIV Protease | Chromatin/Epigenetic; Microbiology/Virology; Proteases/Proteasome |
ZL0580 通过抑制 Tat 反式激活和转录延伸以及通过在 HIV 启动子处诱导抑制性染色质结构来诱导 HIV 抑制。 | |||
T3624 |
A-366
A 366,A366 |
Epigenetic Reader Domain; Histone Methyltransferase | Chromatin/Epigenetic |
A-366 是一种高选择性的肽竞争性组蛋白甲基转移酶 G9a 抑制剂,对 G9a 和 GLP 的 IC50分别为 3.3 和 38 nM。它比其他 21 种甲基转移酶具有 1000 倍以上的选择性。它是 Spindlin1-H3K4me3相互作用的抑制剂,IC50为182.6 nM。它对人 H3R 表现出很高的亲和力,Ki 值为 17 nM,在组胺能和多巴胺能受体家族的亚群间表现出亚型选择性。 | |||
T9703 |
GSK778
|
Epigenetic Reader Domain | Chromatin/Epigenetic |
GSK778 是BET 蛋白BD1溴结构域的选择性抑制剂,对BRD2 BD1、BRD3 BD1、BRD4 BD1、BRDT BD1的IC50分别为75 nM,41 nM,41 nM 和143 nM。 | |||
T14073 |
A-485
|
Epigenetic Reader Domain; Histone Acetyltransferase | Chromatin/Epigenetic |
A-485 是 p300/CBP 的一种选择性催化抑制剂,对 p300和 CBP 组蛋白乙酰转移酶的 IC50值分别为 9.8 和 2.6 nM。 | |||
T6026 |
CPI-203
CPI 203,CPI203 |
Apoptosis; Epigenetic Reader Domain | Apoptosis; Chromatin/Epigenetic |
CPI-203 是一种选择性的,细胞通透的 BET 溴结构域抑制剂,抑制 BRD4,IC50值约为 37 nM。 | |||
T5318 |
666-15
CREB inhibitor |
Epigenetic Reader Domain | Chromatin/Epigenetic |
666-15 (CREB inhibitor) 是一种选择性CREB 抑制剂,IC50为 81 nM,可抑制乳腺癌异种移植模型中的肿瘤生长。 | |||
T60072 |
ZL0590
|
Epigenetic Reader Domain | Chromatin/Epigenetic |
ZL0590 是一种有效的特异性 BD1-BRD4 抑制剂 (IC50 = 90 nM),具有抗炎活性。 | |||
T6828 |
ZL0420
|
Epigenetic Reader Domain | Chromatin/Epigenetic |
ZL0420 是有效且选择性的 BET 溴结构域 4 (BRD4) 抑制剂,对 BRD4 的溴结构域 (BD) 具有纳摩尔结合亲和力。ZL0420 对 BRD4 BD1和 BRD4 BD2 的IC50分别为 27 nM 和 32 nM。 | |||
T15405 |
GNE-781
|
Epigenetic Reader Domain | Chromatin/Epigenetic |
GNE-781 是一种具有口服活性的选择性 CBP 抑制剂,在 TR-FRET 实验中 IC50为 0.94 nM。它还抑制BRET 和BRD4 (1),IC50分别为 6.2 和 5100 nM,有抗肿瘤活性。 |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T6389 |
Anacardic Acid
漆树酸,6-pentadecylsalicylic Acid,Hydroginkgolic acid |
Others; Epigenetic Reader Domain; Histone Acetyltransferase; Antibacterial | Chromatin/Epigenetic; Microbiology/Virology; Others |
Anacardic Acid (6-pentadecylsalicylic Acid) 是从腰果壳中提取液中分离到的酸类物质,是一种组蛋白乙酰转移酶抑制剂,对 p300 和 PCAF 的 IC50值分别为 ∼8.5 μM 和 ∼5 μM。 | |||
T1516 |
Curcumin
Diferuloylmethane,Natural Yellow 3,姜黄素,Indian Saffron,Turmeric yellow |
Mitophagy; Epigenetic Reader Domain; Ferroptosis; Influenza Virus; Nrf2; Histone Acetyltransferase; HDAC; Autophagy | Apoptosis; Autophagy; Chromatin/Epigenetic; DNA Damage/DNA Repair; Immunology/Inflammation; Microbiology/Virology |
Curcumin (Natural Yellow 3) 属于酚类天然产物,是一种组蛋白乙酰化转移酶 p300/CREB 的抑制剂 (IC50=25 μM),具有特异性。Curcumin 具有抗肿瘤、抗炎和抗氧化等多种药理活性。 | |||
T19127 |
3-Phosphoglyceric acid
|
Others | Others |
3-Phosphoglyceric acid is a metabolic intermediate in both glycolysis and the Calvin cycle. It is involved in alveolar macrophage epigenetic regulation. | |||
T5270 |
5-Methylcytosine
|
Others; DNA/RNA Synthesis; Endogenous Metabolite | Cell Cycle/Checkpoint; DNA Damage/DNA Repair; Metabolism; Others |
5-Methylcytosine 是一种存在于真核 DNA 中的甲基化核苷酸碱基。它是由 DNA 甲基转移酶作用形成的表观遗传修饰。 | |||
TN2286 |
Tsugaric acid A
|
NO Synthase | Immunology/Inflammation |
Tsugaric acid A 能够显著抑制超氧阴离子的形成,还可以保护人类角质形成细胞,使其免受紫外线 B 诱导的损害。 | |||
T5255 |
5-Hydroxymethyluracil
5-(Hydroxymethyl)uracil,5-羟甲基脲嘧啶,Hydroxymethyl Uracil,a-Hydroxythymine |
Others; Endogenous Metabolite | Metabolism; Others |
5-(Hydroxymethyl)uracil 是一种氧化性 DNA 损伤的产物,能够增强或抑制细菌 RNA 聚合酶转录的潜在表观遗传标记。 | |||
TN1691 |
Glabrol
光甘草酚,光甘草醇 |
P450; NF-κB; NO Synthase; Acyltransferase | Immunology/Inflammation; Metabolism; NF-κB |
Glabrol 是分离自甘草根的乙醇提取物中的一种异戊二烯类黄酮,是一种有效且非竞争性的酰基辅酶 A:胆固醇酰基转移酶(ACAT)抑制剂,抑制大鼠肝脏微粒体 ACAT 的IC50为 24.6 μM。 | |||
T66903 |
Gallic Acid Monohydrate
|
Others | Others |
Gallic acid may be used as a standard in the photometric determination of total phenolics content by Folin-Ciocalteu method with potential role in epigenetic therapy of human cancers. | |||
T13749 |
L-2-Hydroxyglutaric acid
(S)-2-Hydroxyglutaric acid |
Others | Others |
L-2-Hydroxyglutaric acid, an epigenetic modifier and potential oncometabolite in renal cancer, impedes mitochondrial creatine kinase (Mi-CK) activity, exhibiting Km and Ki values of 2.52 mM and 11.13 mM, respectively. Additionally, it obstructs histone demethylases, thereby encouraging histone methylation. | |||
TN7258 |
3-Methylcytidine methosulfate
|
Others | Others |
3-Methylcytidine (methosulfate), a derivative of cytidine, serves as an internal standard for HPLC and is recognized for its epigenetic modification in tRNA, although its cellular role remains unclear. Research has explored its utility as a cancer biomarker, with findings indicating a notable increase in the urine of breast cancer patients. |
Cat. No. | Product Name | Species | Expression System |
---|---|---|---|
TMPY-00365 |
GALNT7 Protein, Human, Recombinant (His)
GalNAcT7,polypeptide N-acetylgalactosaminyltransferase 7,GAL... |
Human | HEK293 Cells |
GalNAc-transferase-7 (GALNT7) is essential for the regulation of cell proliferation and has been implicated in tumorigenesis. Colorectal cancer (CRC) arises in a multistep molecular network process, which is from either discrete genetic perturbation or epigenetic dysregulation. GALNT7 acts as a glycosyltransferase in protein O-glycosylation, involving in the occurrence and development of CRC. GALNT7 silencing significantly attenuated the proliferation, clonogenicity and migration of LSCC cells a... | |||
TMPY-02030 |
CD82 Protein, Human, Recombinant (His)
CD82 molecule,SAR2,R2,KAI-1,4F9,KAI1,C33,TSPAN27,ST6,IA4,GR1... |
Human | HEK293 Cells |
CD82, also known as KAI-1, structurally belongs to tetraspanin family while categorised as metastasis suppressor gene on functional grounds. KAI1/CD82 is localized on cell membrane and form interactions with other tetraspanins, integrins and chemokines which are respectively responsible for cell migration, adhesion and signalling. Downregulation of CD82 expression is associated with the advanced stages of many human cancers and correlates with the acquisition of metastatic potential. Recent stud... | |||
TMPY-00150 |
IGF2/IGF-II Protein, Human, Recombinant
PP9974,胰岛素样生长因子,C11orf43,IGF-II,insulin-like growth factor 2 |
Human | P. pastoris (Yeast) |
Insulin-like growth factor 2 (IGF-2/IGF-II) is a member of the insulin family of polypeptide growth factors, which are involved in development and growth. It is an imprinted gene, expressed only from the paternal allele, and epigenetic changes at this locus are associated with Wilms tumor, Beckwith-Wiedemann syndrome, rhabdomyosarcoma, and Silver-Russell syndrome. IGF-2/IGF-II is a mediator of prolactin-induced alveologenesis; prolactin, IGF-2, and cyclin D1, all of which are overexpressed in br... | |||
TMPY-02378 |
14‑3‑3 theta/YWHAQ Protein, Human, Recombinant (GST)
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activati... |
Human | E. coli |
The recently identified 14-3-3 tau, whose corresponding gene name is YWHAQ, is in a hypoxia-treated human trophoblast cell line. YWHAQ may play a role in epigenetic regulation of placental genes in the onset of Preeclampsia (PE). Moreover, there was a closer relationship between blood pressure and methylation levels of the YWHAQ promoter. | |||
TMPH-00095 |
HDT2 Protein, Arabidopsis thaliana, Recombinant (His)
Histone deacetylase HDT2,Histone deacetylase 2b,HD-tuins pro... |
Arabidopsis thaliana | P. pastoris (Yeast) |
Probably mediates the deacetylation of lysine residues on the N-terminal part of the core histones (H2A, H2B, H3 and H4). Histone deacetylation gives a tag for epigenetic repression and plays an important role in transcriptional regulation, cell cycle progression and developmental events. HDT2 Protein, Arabidopsis thaliana, Recombinant (His) is expressed in yeast with N-6xHis tag. The predicted molecular weight is 34.3 kDa and the accession number is Q56WH4. | |||
TMPH-02908 |
AICDA Protein, Mouse, Recombinant (His & Myc)
Single-stranded DNA cytosine deaminase,Cytidine aminohydrola... |
Mouse | E. coli |
Single-stranded DNA-specific cytidine deaminase. Involved in somatic hypermutation (SHM), gene conversion, and class-switch recombination (CSR) in B-lymphocytes by deaminating C to U during transcription of Ig-variable (V) and Ig-switch (S) region DNA. Required for several crucial steps of B-cell terminal differentiation necessary for efficient antibody responses. May also play a role in the epigenetic regulation of gene expression by participating in DNA demethylation. | |||
TMPJ-00694 |
BRD4 Protein, Human, Recombinant (His & Flag)
MCAP,HUNK1,HUNKI,bromodomain-containing protein 4 |
Human | E. coli |
Bromodomain-containing protein 4 (BRD4) is a member of the BET class chromatin reader proteins that bind acetylated histones and play a key role in transcriptional regulation and transmission of epigenetic memory. Remains associated with acetylated chromatin throughout the entire cell cycle and provides epigenetic memory for postmitotic G1 gene transcription by preserving acetylated chromatin status and maintaining high-order chromatin structure. BRD bromodomains serve as recognition motifs for ... | |||
TMPH-01472 |
HDAC11 Protein, Human, Recombinant (GST)
HDAC11,Histone deacetylase 11 |
Human | E. coli |
Responsible for the deacetylation of lysine residues on the N-terminal part of the core histones (H2A, H2B, H3 and H4). Histone deacetylation gives a tag for epigenetic repression and plays an important role in transcriptional regulation, cell cycle progression and developmental events. Histone deacetylases act via the formation of large multiprotein complexes. HDAC11 Protein, Human, Recombinant (GST) is expressed in E. coli expression system with N-GST tag. The predicted molecular weight is 66.... | |||
TMPJ-00986 |
CTCF Protein, Human, Recombinant
Transcriptional Repressor CTCF,CCCTC-Binding Factor,CTCFL Pa... |
Human | E. coli |
Transcriptional Repressor CTCF (CTCF) belongs to the CTCF Zinc-Finger Protein family. CTCF contains twelve C2H2-type zinc fingers and interacts with CHD8. CTCF is widely expressed in many tissues, and it is absent in primary spermatocytes. CTCF is involved in transcriptional regulation by binding to chromatin insulators and preventing interaction between promoter and nearby enhancers and silencers. CTCF plays an essential role in oocyte and preimplantation embryo development by activating or rep... | |||
TMPK-00710 |
Claudin-4 Protein-VLP, Human, Recombinant
Claudin4,CLDN4,Claudin-4,CPETR1,CPE-R,WBSCR8,CPE R |
Human | HEK293 Cells |
Claudin-4 (CLDN4) is a key component of tight junctions (TJs) in epithelial cells. CLDN4 is overexpressed in many epithelial malignancies and correlates with cancer progression. Changes in CLDN4 expression have been associated with epigenetic factors (such as hypomethylation of promoter DNA), inflammation associated with infection and cytokines, and growth factor signaling. CLDN4 helps to maintain the tumor microenvironment by forming TJs and acts as a barrier to the entry of anticancer drugs in... | |||
TMPH-02175 |
TAF5L Protein, Human, Recombinant (GST)
TAF5L,TAF5-like RNA polymerase II p300/CBP-associated factor... |
Human | E. coli |
Functions as a component of the PCAF complex. The PCAF complex is capable of efficiently acetylating histones in a nucleosomal context. The PCAF complex could be considered as the human version of the yeast SAGA complex. With TAF6L, acts as an epigenetic regulator essential for somatic reprogramming. Regulates target genes through H3K9ac deposition and MYC recruitment which trigger MYC regulatory network to orchestrate gene expression programs to control embryonic stem cell state. | |||
TMPH-01088 |
CBX5 Protein, Human, Recombinant (His & Myc)
HP1 alpha,CBX5,Heterochromatin protein 1 homolog alpha,Chrom... |
Human | E. coli |
Component of heterochromatin that recognizes and binds histone H3 tails methylated at 'Lys-9' (H3K9me), leading to epigenetic repression. In contrast, it is excluded from chromatin when 'Tyr-41' of histone H3 is phosphorylated (H3Y41ph). Can interact with lamin-B receptor (LBR). This interaction can contribute to the association of the heterochromatin with the inner nuclear membrane. Involved in the formation of functional kinetochore through interaction with MIS12 complex proteins. CBX5 Protein... | |||
TMPY-03332 |
PRTFDC1 Protein, Human, Recombinant (His)
HHGP,PRTFDC1,phosphoribosyl transferase domain containing 1 |
Human | E. coli |
PRTFDC1 is a member of the purine/pyrimidine phosphoribosyltransferase family. It can bind GMP, IMP and alpha-D-5-phosphoribosyl 1-pyrophosphate (PRPP). The epigenetic silencing of PRTFDC1 by hypermethylation of the CpG island leads to a loss of PRTFDC1 function, which might be involved in squamous cell oral carcinogenesis. PRTFDC1 is a genetic modifier of HPRT-deficiency in the mouse and has important implications for unraveling the molecular etiology of lesch-Nyhan disease(LND). LND is a sever... | |||
TMPH-01235 |
APOBEC3A Protein, Human, Recombinant (His & SUMO)
A3A,APOBEC3A,DNA dC->dU-editing enzyme APOBEC-3A,Phorbolin-1 |
Human | E. coli |
DNA deaminase (cytidine deaminase) with restriction activity against viruses, foreign DNA and mobility of retrotransposons. Exhibits antiviral activity against adeno-associated virus (AAV) and human T-cell leukemia virus type 1 (HTLV-1) and may inhibit the mobility of LTR and non-LTR retrotransposons. Selectively targets single-stranded DNA and can deaminate both methylcytosine and cytosine in foreign DNA. Can induce somatic hypermutation in the nuclear and mitochondrial DNA. May also play a rol... | |||
TMPJ-00790 |
GSN Protein, Human, Recombinant (mFc)
ADF,Actin-depolymerizing factor,Brevin,Gelsolin,GSN,AGEL |
Human | HEK293 Cells |
Gelsolin is a calcium-activated actin filament severing and capping protein found in many cell types and as a secreted form in the plasma of vertebrates. Gelsolin is composed of six of these domains, termed G1-6. Some reaseraches show that gelsolin can act as a transcriptional cofactor in signal transduction and its own expression and function can be influenced by epigenetic changes. The difference in the expression levels of cytoplasmic and plasma gelsolin suggests that these two different form... | |||
TMPY-00519 |
Gastrokine 1 Protein, Human, Recombinant (His)
UNQ489/PRO1005,CA11,foveolin,BRICD1,AMP18,gastrokine 1,FOV |
Human | Baculovirus Insect Cells |
Gastrokine 1 (GKN1) belongs to the BRICHOS domain family and plays a major role in maintaining gastric mucosa integrity. GKN1 is highly expressed in gastric tissue and is secreted into the stomach but is not expressed in gastric cancer. GKN1-mediated inhibition of APP processing might represent a new approach for the prevention and therapy of Alzheimer's disease (AD). In the presence of GKN2, GKN1 loses its ability to decrease cell proliferation, induce apoptosis, and inhibit epigenetic alterati... | |||
TMPY-02979 |
HMGN3 Protein, Human, Recombinant (His)
PNAS-24,TRIP7,PNAS-25,high mobility group nucleosomal bindin... |
Human | E. coli |
HMGN3 belongs to the HMGN family and is expressed in the kidney, lung, pancreas, testis, skeletal muscle, heart, thyroid gland, pituitary gland, prostate, and uterus. Members of the HMGN family bind to nucleosomes without any specificity for the underlying DNA sequence. They affect the global and local structure of chromatin, as well as the levels of histone modifications, and thus play a role in epigenetic regulation of gene expression. HMGN3 regulates the expression of the glucose transporter ... | |||
TMPY-02957 |
DYDC2 Protein, Human, Recombinant (GST)
DPY30 domain containing 2 |
Human | E. coli |
DPY30 domain containing 2 belongs to the dpy-30 family. Dumpy-30 family members act as determinants of male fertility and interaction partners of metal-responsive transcription factor 1 (MTF-1) in Drosophila. MTF-1 plays a key role in transition metal detoxification and homeostasis. It binds to metal response elements (MREs). Two candidate dMTF-1 interactors are related to the small regulatory protein Dumpy-30 (Dpy-30) of the worm C. elegans. Dpy-30 is the founding member of a protein family inv... | |||
TMPY-01657 |
SUV420H2 Protein, Human, Recombinant (His & GST)
suppressor of variegation 4-20 homolog 2 (Drosophila),KMT5C |
Human | E. coli |
Histone-lysine N-methyltransferase SUV42H2, also known as Suppressor of variegation 4-2 homolog 2, Su(var)4-2 homolog 2, Lysine N-methyltransferase 5C, SUV42H2 and KMT5C, is nucleus protein that belongs to the histone-lysine methyltransferase family and Suvar4-2 subfamily. SUV42H2 is a histone methyltransferase that specifically trimethylates 'Lys-2' of histone H4. H4 'Lys-2' trimethylation represents a specific tag for epigenetic transcriptional repression. SUV42H2 mainly functions in pericentr... | |||
TMPY-00585 |
Annexin A8 Protein, Human, Recombinant (His)
ANX8,annexin A8 |
Human | E. coli |
We have previously shown that Annexin A8 (ANXA8) is strongly associated with the basal-like subgroup of breast cancers, including BRCA1-associated breast cancers, and poor prognosis; while in the mouse mammary gland AnxA8 mRNA is expressed in low-proliferative isolated pubertal mouse mammary ductal epithelium and after enforced involution, but not in isolated highly proliferative terminal end buds (TEB) or during pregnancy. ANXA8 as a potential mediator of quiescence in the normal mouse mammary ... |